share_log

JMP Securities Maintains Market Outperform on Cue Biopharma, Lowers Price Target to $2

JMP Securities Maintains Market Outperform on Cue Biopharma, Lowers Price Target to $2

JMP证券维持cue biopharma市场表现,但将目标价下调至2美元
Benzinga ·  07/26 14:12  · 评级/大行评级

JMP Securities analyst Reni Benjamin maintains Cue Biopharma (NASDAQ:CUE) with a Market Outperform and lowers the price target from $15 to $2.

JMP证券分析师Reni Benjamin认为Cue Biopharma(纳斯达克股票代码:CUE)的市场表现优异,并将其价格目标从15美元降至2美元。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发